NCT05196386

Usual Care Intervention Research Evaluating the Impact of a Personalized Pharmaceutical Plan on the Duration of Opioid Treatment in Non-cancerous Pain

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: University Hospital, Rouen · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

Many treatments with WHO grade III opioids are being introduced in the rheumatology department for non-cancerous pain. The duration of this treatment prescribed at discharge is often uncontrolled and sometimes leads to significant addiction. The team at the local pain center recommends an average duration of 28 days for this type of pain. There is a full-time pharmacy intern in the rheumatology department. The aim of this work is to evaluate the impact of a targeted pharmaceutical interview on the duration of the morphine treatment initiated during hospitalization.

Conditions

• Non-cancerous Pain
• Opioid Use

Interventions

Type	Name	Description
BEHAVIORAL	Admission conciliation interview	Previous treatment conciliation at hospital admission
BEHAVIORAL	Discharge conciliation interview	Allocated treatment during hospital stay
BEHAVIORAL	Targeted pharmaceutical interview	Specific information about treatment delivered by pharmacist

Timeline

• Start date: 2020-08-06
• Primary completion: 2023-08-28
• Completion: 2023-08-28
• First posted: 2022-01-19
• Last updated: 2025-09-11

Locations

1 site across 1 country: France